Literature DB >> 11281184

Similar T-cell oligoclonality in antimitochondrial antibody-positive and -negative primary biliary cirrhosis.

M J Mayo1, P E Lipsky, S N Miller, P Stastny, B Combes.   

Abstract

Approximately 5% of patients with clinical and histological features suggestive of primary biliary cirrhosis do not have anti-mitochondrial antibodies that can be detected by current methodologies. Although the role of these autoantibodies in the pathogenesis of liver disease is uncertain, T lymphocytes within the portal tracts are felt to be important mediators of bile duct destruction. In order to investigate the hypothesis that a similar T-cell process may be involved in both antimitochondrial antibody-positive and -negative primary biliary cirrhosis, we characterized the oligoclonally expanded T cells in both types of patients by analysis of complementarity determining region 3 length in peripheral blood mononuclear cells. The distribution of oligoclonally expanded T cells was similar in both groups. This finding does not support a distinct T-cell-mediated pathogenesis for anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis but rather suggests that similar processes may be involved in the immunopathogenesis of both.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11281184     DOI: 10.1023/a:1005609100900

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  T-cell receptor Vbeta gene utilization in primary biliary cirrhosis.

Authors:  M J Mayo; B Combes; R N Jenkins
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

2.  T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones.

Authors:  U Moebius; M Manns; G Hess; G Kober; K H Meyer zum Büschenfelde; S C Meuer
Journal:  Eur J Immunol       Date:  1990-04       Impact factor: 5.532

3.  Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?

Authors:  P Sánchez-Pobre; G Castellano; F Colina; P Dominguez; S Rodriguez; F Canga; J A Herruzo
Journal:  J Clin Gastroenterol       Date:  1996-10       Impact factor: 3.062

Review 4.  T-cell autoimmunity in primary biliary cirrhosis.

Authors:  D E Jones
Journal:  Clin Sci (Lond)       Date:  1996-11       Impact factor: 6.124

5.  T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis.

Authors:  D E Jones; J M Palmer; O F James; S J Yeaman; M F Bassendine; A G Diamond
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

6.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

7.  Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype.

Authors:  J Underhill; P Donaldson; G Bray; D Doherty; B Portmann; R Williams
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

8.  Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins: implications for studies of infectious and autoimmune diseases.

Authors:  J Monteiro; R Hingorani; I H Choi; J Silver; R Pergolizzi; P K Gregersen
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

9.  Is mitochondrial antibody diagnostic of primary biliary cirrhosis?

Authors:  L E Munoz; H C Thomas; P J Scheuer; D Doniach; S Sherlock
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

10.  Limited T-cell receptor diversity in liver-infiltrating lymphocytes from patients with primary biliary cirrhosis.

Authors:  A Diu; U Moebius; L Ferradini; C Genevée; S Roman-Roman; M Claudon; D Delorme; S Meuer; T Hercend; F Praz
Journal:  J Autoimmun       Date:  1993-10       Impact factor: 7.094

View more
  2 in total

1.  Characterization of M2 antibodies in asymptomatic Chinese population.

Authors:  Xiao-Hua Jiang; Ren-Qian Zhong; Xiao-Yun Fan; Yin Hu; Feng An; Jian-Wen Sun; Xian-Tao Kong
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

2.  Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis.

Authors:  Xiao-Hua Jiang; Ren-Qian Zhong; Sheng-Qian Yu; Yin Hu; Weng-Weng Li; Xian-Tao Kong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.